日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trial

对于不适合接受根治性化疗的老年经典型霍奇金淋巴瘤患者,Brentuximab vedotin 单药治疗是一种可行且有效的治疗方法:来自前瞻性 GHSG-NLG II 期 BVB 试验的结果

Fosså, Alexander; Molin, Daniel; Bröckelmann, Paul J; Schneider, Gundolf; Schnetzke, Ulf; Linderoth, Johan; Kamper, Peter M H; Leppä, Sirpa M; Meissner, Julia; Schaub, Valdete; Lia, Kjersti; Fuchs, Michael; Borchmann, Peter; Böll, Boris

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

布伦妥昔单抗、环磷酰胺、多柔比星和泼尼松用于治疗老年晚期霍奇金淋巴瘤患者

Bröckelmann, Paul J; Böll, Boris; Molin, Daniel; Schneider, Gundolf; Leppä, Sirpa; Meissner, Julia; Kamper, Peter; Hutchings, Martin; Christensen, Jacob H; Schnetzke, Ulf; Fuchs, Michael; Jablonski, Janina; Eichenauer, Dennis A; von Tresckow, Bastian; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Fosså, Alexander

Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials

晚期经典型霍奇金淋巴瘤患者在接受 2 个疗程 ABVD 化疗后,中期 PET-2 Deauville 评分达到 5 分:三项多中心试验的汇总分析

Viviani, Simonetta; Pavoni, Chiara; Barrington, Sally F; Guerra, Luca; Schöder, Heiko; Johnson, Peter; Kirkwood, Amy A; Stephens, Deborah M; Friedberg, Jonathan W; Chauvie, Stephane; Knopp, Michael V; Luminari, Stefano; Molin, Daniel; Corradini, Paolo; Gallamini, Andrea; Rambaldi, Alessandro; Tarella, Corrado

A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma

简化的衰弱评分可预测接受根治性治疗的经典型霍奇金淋巴瘤老年患者的预后

Lia, Kjersti; Jørgensen, Rasmus Rask Kragh; Wikman, Per; Wold, Bente L; Övergaard, Ninja; Fluge, Øystein; Fagerli, Unn-Merete; Bersvendsen, Hanne; Bø, Idun B; Bhargava, Sameer; Molin, Daniel; Fosså, Alexander

Response to Comment on: "A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma"

对以下评论的回应:“简化的衰弱评分可预测接受根治性治疗的经典霍奇金淋巴瘤老年患者的预后”

Lia, Kjersti; Jørgensen, Rasmus Rask Kragh; Wikman, Per; Wold, Bente L; Övergaard, Ninja; Fluge, Øystein; Fagerli, Unn-Merete; Bersvendsen, Hanne; Bø, Idun B; Bhargava, Sameer; Molin, Daniel; Fosså, Alexander

Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

探索性研究:血浆蛋白质组学与霍奇金淋巴瘤心脏毒性的关联

Ulfstedt, Johan Mattsson; Risebro, Ragnhild; Freyhult, Eva; Christersson, Christina; Mörth, Charlott; Kamali-Moghaddam, Masood; Robelius, Anna; Enblad, Gunilla; Molin, Daniel

Improved therapies, incomplete data: late toxicity after modern classical Hodgkin Lymphoma radiotherapy

疗法改进,但数据不完整:现代经典霍奇金淋巴瘤放射治疗后的远期毒性

Molin, Daniel

Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial

晚期霍奇金淋巴瘤反应调整治疗试验的长期随访

Luminari, Stefano; Fossa, Alexander; Trotman, Judith; Molin, Daniel; d'Amore, Francesco; Enblad, Gunilla; Berkahn, Leanne; Barrington, Sally F; Radford, John; Federico, Massimo; Kirkwood, Amy A; Johnson, Peter W M

Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors

基于多方向二维投影先验信息的全身三维扫描中肿瘤自动分割的改进

Tarai, Sambit; Lundström, Elin; Sjöholm, Therese; Jönsson, Hanna; Korenyushkin, Alexander; Ahmad, Nouman; Pedersen, Mette A; Molin, Daniel; Enblad, Gunilla; Strand, Robin; Ahlström, Håkan; Kullberg, Joel

Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival - a Swedish Lymphoma Register Study

COVID-19 大流行对淋巴瘤发病率和短期生存率的影响——一项瑞典淋巴瘤登记研究

Ekberg, Sara; Molin, Daniel; Pahnke, Simon; Bergström, Fanny; Brånvall, Elsa; Smedby, Karin E; Wästerlid, Tove